SHC (Sotera Health Co) Momentum Rank: 8 (As of Sep. 02, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHC Sotera Health Co SHC
75 GF Score
Price $19.00
GF Value $16.43
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Sotera Health Co Momentum Rank?

Sotera Health Co SHC +1.71% 75 Momentum Rank is 8 as of Sep. 02, 2026, which is at its 10-year median of 8.00. GuruFocus rates SHC with a GF Score™ of 75/100 and a GF Value™ of $16.43 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Sotera Health Co has the Momentum Rank of 8.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Sotera Health Co Momentum Rank Related Terms

SHC vs RDNT, BLLN, ADPT: Momentum Rank Comparison

For the Diagnostics & Research subindustry, Sotera Health Co's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sotera Health Co Momentum Rank vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Sotera Health Co's Momentum Rank falls into.


SHC
75GF Score
Sotera Health Co SHC
Momentum Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Momentum Rank →
What does a Momentum Rank of 8 mean?
Sotera Health Co (SHC) has a Momentum Rank of 8 as of Sep. 02, 2026. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Sotera Health Co and its competitors. This is near median its historical median of 8.00. Over the past decade, Sotera Health Co's Momentum Rank has ranged from 5.00 to 10.00.
Is Sotera Health Co's Momentum Rank too high?
Sotera Health Co's current Momentum Rank of 8 is near median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 10.00. Overall, Sotera Health Co has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's Momentum Rank compare to RDNT and BLLN?
Sotera Health Co's Momentum Rank of 8 can be compared against companies in the Medical Diagnostics & Research industry. Historically, Sotera Health Co's own Momentum Rank has ranged from 5.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Momentum Rank for a Medical Diagnostics & Research company?
A good Momentum Rank depends on the Medical Diagnostics & Research industry context. However, Momentum Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Momentum Rank mean?
A high Momentum Rank can signal that a stock is expensive relative to its fundamentals. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Sotera Health Co and its competitors. Sotera Health Co's current Momentum Rank is 8, which is near median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $16.43, compared to a current price of $19.00 — trading 15.6% above its estimated fair value. The current Momentum Rank is 8, which is near median its 10-year median of 8.00. Sotera Health Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Momentum Rank calculated?
Momentum Rank is calculated from a company's financial statements. For Sotera Health Co (SHC), the current Momentum Rank is 8 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $19.00 is trading 15.6% above its estimated GF Value™ of $16.43. GuruFocus considers Sotera Health Co to be Modestly Overvalued.

Key valuation signals for SHC:

  • Momentum Rank: 8 (near median its 10-year median of 8.00)
  • GF Value™: $16.43 vs. price of $19.00 (15.6% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
75GF Score

Get the complete analysis for SHC

Momentum Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.00
Price
$16.43
GF Value